FDA Approves Jaypirca (Pirtobrutinib) for Two Rare Blood Cancers by Madaline Spencer| Published on: Oct 13, 2026

https://checkrare.com/fda-approves-jaypirca-pirtobrutinib-for-two-rare-blood-cancers/ The US Food and Drug Administration (FDA) has approved pirtobrutinib for adults with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) with no known 17p deletion.